Lacosamide Tablets 50mg Recalled for CGMP Manufacturing Deviations
Glenmark Pharmaceuticals Inc., USA is voluntarily recalling Lacosamide Tablets 50mg due to Current Good Manufacturing Practice (CGMP) deviations. The recall affects specific lots distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is FDA Class II for CGMP deviations without any reported illnesses or injuries. Under the rubric, Class II recalls without hospitalization reports are typically Moderate severity.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA is voluntarily recalling Lacosamide Tablets, 50mg, in 60-count bottles (NDC# 68462-678-60) due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing. The affected lots are #17240221 and #17240222, both with expiration date January 2026.
The product was distributed nationwide in the United States. Lacosamide is a prescription oral medication used to treat seizures. The FDA has classified this recall as Class II.
Patients currently taking Lacosamide from affected lots should contact their healthcare provider or pharmacist before stopping the medication. Healthcare providers and patients should report any adverse events to the FDA's MedWatch program.
The recalled product
- Product
- LACOSAMIDE (LACOSAMIDE)
- Brand
- LACOSAMIDE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Hazard
- cgmp-deviation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # 17240221
- exp. date Jan-26 17240222
- exp. date Jan-26
UPCs (4)
- 0368462681602
- 0368462679609
- 0368462678602
- 0368462680605
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LACOSAMIDE
- HighLacosamide 100mg Tablets Recalled Due to Foreign Tablet Contamination
FDA (Drugs) · 2026-07-01
- HighFDA Recalls Lacosamide Tablets for Manufacturing Quality Deviations
FDA (Drugs) · 2025-04-16
- ModerateGlenmark Lacosamide 100mg Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-16
- ModerateLacosamide Tablets 200mg Recalled Due to CGMP Deviations
FDA (Drugs) · 2025-04-16
- ModerateLacosamide oral solution recalled for failed excipient specifications
FDA (Drugs) · 2022-12-21
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22